Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Peter MacCallum Cancer Centre
Scientific Title
A Phase I/II Trial of the combination of BRAF and EGFR inhibition in BRAF V600E mutant colorectal, advanced or metastatic lung adenocarcinoma and other cancers.